Pregabalin for chronic pain: does one medication fit all?

References

• Silverman RB. From basic sciences to blockbuster drug: the discovery of Lyrica. Angew Chem Int Ed Engl 2008;47:3500-4
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Kirkpatrick P. Pregabalin. Nat Rev Drug Discov 2005;4:455-56
   PubMed Web of Science ®Google Scholar
• FDA highlights of prescribing information (online). Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf [Last accessed 16 April 2014]
   Google Scholar
• Lyrica European Union Prescribing Information (online). Available at: http://www.medicines.org.uk/EMC/medicine/14707/PIL/Lyrica+Capsules [Last accessed 16 April 2014]
   Google Scholar
• Lyrica product monograph 2013. Available at http://www.pfizer.ca/en/our_products/products/monograph/141 [Last accessed 16 April 2014]
   Google Scholar
• Tassone DM, Boyce E, Guyer J, et al. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures and anxiety disorders. Clin Ther 2007;29:26-48
   PubMed Web of Science ®Google Scholar
• Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400
   PubMed Web of Science ®Google Scholar
• Rosenberg JM, Harrell C, Ristic H, et al. The effect of gabapentin in neuropathic pain. Clin J Pain 1997;13:251-5
   PubMed Web of Science ®Google Scholar
• Tanenberg RJ, Irving GA, Risser RC, et al. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. Mayo Clin Proc 2011;86:615-26
   PubMed Web of Science ®Google Scholar
• Ray WA, Meredith S, Thapa PB, et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004;75:234-41
   PubMed Web of Science ®Google Scholar
• Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000;108:2-8
   PubMed Web of Science ®Google Scholar
• Guay DRP. Pregabalin in neuropathic pain: a more ‘pharmaceutically elegant’ gabapentin? Am J Geriatr Pharmacother 2005;3:274-87
   PubMedGoogle Scholar
• Bockbrader HN, Wesche D, Miller R, et al. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 2010;49:661-9
   PubMed Web of Science ®Google Scholar
• Cymbalta product monograph 2015. Available at: http://www.lilly.ca/en/pdf/product-monograph/18_cymbalta-pm_11mar2015.pdf [Last accessed 7 April 2015]
   Google Scholar
• Mesgarpour B, Müller M, Herkner H. Search strategies to identify reports on ‘off-label’ drug use in EMBASE. BMC Med Res Methodol 2012;12:190
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19
   PubMed Web of Science ®Google Scholar
• Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:337-45
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA, Ste-Marie PA, Gamsa A, et al. Opioid use, misuse and abuse in patients labeled as fibromyalgia. Am J Med 2011;124:955-60
   PubMed Web of Science ®Google Scholar
• Limesurvey online survey software. Available at: http://www.limesurvey.org [Last accessed 3 March 2013]
   Google Scholar
• Haythornthwaite JA, Fauerbach JA. Assessment of acute pain, pain relief and patient satisfaction. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment, 2nd edn. New York: Guilford Press, 2001:417-30
   Google Scholar
• Dworkin RH, Nagasako EM, Hetzel RD, et al. Assessment of pain and pain-related quality of life in clinical trials. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment, 2nd edn. New York: Guilford Press, 2001:659-92
   Google Scholar
• Tylenol professional product information. Available at: http://www.tylenolprofessional.com/assets/TYL_PPI.pdf page 5 [Last accessed 16 April 2014]
   Google Scholar
• Ultram product monograph. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020281s032s033lbl.pdf [Last accessed 16 April 2014]
   Google Scholar
• Goldman DA. Thalidomide use: past history and current implications for practice. Oncol Nurs Forum 2001;28:471-7
   PubMedGoogle Scholar
• Vanchieri C. Preparing for thalidomide comeback. Ann Intern Med 1997;127:951-2
   PubMed Web of Science ®Google Scholar
• Rinsema TJ. One hundred years of aspirin. Med Hist 1999;43:502-7
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet 2009;373:1849-60
   PubMed Web of Science ®Google Scholar
• Pakravan M, Roshani M, Yazdani S, et al. Pregabalin and gabapentin for post-photorefractive keratectomy pain: a randomized controlled trial. Eur J Ophthalmol 2012;22(Suppl 7):s106-13
   PubMed Web of Science ®Google Scholar
• Balaban F, Yağar S, Özgök A, et al. A randomized, placebo-controlled study of pregabalin for postoperative pain intensity after laparoscopic cholecystectomy. J Clin Anesth 2012;24:175-8
   PubMed Web of Science ®Google Scholar
• Bornemann-Cimenti H, Lederer AJ, Wejbora M, et al. Preoperative pregabalin administration significantly reduces postoperative opioid consumption and mechanical hyperalgesia after transperitoneal nephrectomy. Br J Anaesth 2012;108:845-9
   PubMed Web of Science ®Google Scholar
• Nimmaanrat S, Tangtrakulwanish B, Klabklay P, et al. Perioperative administration of pregabalin in patients undergoing arthroscopic anterior cruciate ligament reconstruction: does it help to relieve postoperative pain? J Med Assoc Thai 2012;95:1297-301
   PubMedGoogle Scholar
• Paech MJ, Goy R, Chua S, et al. A randomized, placebo-controlled trial of preoperative oral pregabalin for postoperative pain relief after minor gynecological surgery. Anesth Analg 2007;105:1449-53
   PubMed Web of Science ®Google Scholar
• YaDeau JT, Paroli L, Kahn RL, et al. Addition of pregabalin to multimodal analgesic therapy following ankle surgery: a randomized, double-blind, placebo-controlled trial. Reg Anesth Pain Med 2012;37:302-7
   PubMed Web of Science ®Google Scholar
• Romanò CL, Romanò D, Bonora C, et al. Pregabalin, celecoxib and their combination for treatment of low back pain. J Orthoped Traumatol 2009;10:185-91
   PubMedGoogle Scholar
• Olesen SS, Bouwense SA, Wilder-Smith OH, et al. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology 2011;141:536-43
   PubMed Web of Science ®Google Scholar
• Rizzato B, Leone G, Misaggi G, et al. Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label, prospective study. Clin Neuropharmacol 2011;34:74-8
   PubMed Web of Science ®Google Scholar
• Pontari MA, Krieger JN, Litwin MS, et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med 2010;170:1586-93
   PubMed Web of Science ®Google Scholar
• Baron R, Freynhagen R, Tölle TR, et al. The efficacy and safety of pregabalin in the treatments of pain associated with chronic lumbosacral radiculopathy. Pain 2010;150:420-7
   PubMed Web of Science ®Google Scholar
• Navarro A, Saldaña MT, Pérez C, et al. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings. Pain Med 2010;11:719-31
   PubMed Web of Science ®Google Scholar
• Moon DE, Lee DI, Lee SC, et al. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Clin Ther 2010;32:2370-85
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-73
   PubMed Web of Science ®Google Scholar
• Smith MT, Moore BJ. Pregabalin for the treatment of fibromyalgia. Expert Opin Pharmacother 2012;13:1527-33
   PubMed Web of Science ®Google Scholar
• Bandelow B, Sher L, Bunevicius R, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 2012;16:77-84
   PubMed Web of Science ®Google Scholar
• Wensel TM, Powe KW, Cates ME. Pregabalin for the treatment of generalized anxiety disorder. Ann Pharmacoth 2012;46:424-9
   PubMed Web of Science ®Google Scholar
• Crombez G, Eccleston C, Van Damme S, et al. Fear-avoidance model of chronic pain: the next generation. Clin J Pain 2012;28:475-83
   PubMed Web of Science ®Google Scholar
• Zin CS, Nissen LM, O’Callaghan JP, et al. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. J Pain 2010;11:462-71
   PubMed Web of Science ®Google Scholar
• Tzellos TG, Papazisis G, Toulis KA, et al. A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice. Hippokratia 2010;14:71-5
   PubMed Web of Science ®Google Scholar